Literature DB >> 4231599

Urinary 17-ketosteroid excretion of women with advanced breast cancer.

S Kumaoka, N Sakauchi, O Abe, M Kusama, O Takatani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4231599     DOI： 10.1210/jcem-28-5-667

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  6 in total

1.  Hormonal influences in breast cancer.

Authors:  A P Forrest
Journal:  Proc R Soc Med       Date:  1971-05

2.  Urinary androgen and 17-hydroxylated corticosteroid metabolites and their relation to recurrence rates in early breast cancer.

Authors:  B S Thomas; R D Bulbrook; M J Russell; J L Hayward; R R Millis
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

3.  Abnormal excretion of corticosteroid sulphates in patients with breast cancer.

Authors:  P C Ghosh; E Lockwood; G W Pennington
Journal:  Br Med J       Date:  1973-02-10

Review 4.  Differentiation of the mammary gland and susceptibility to carcinogenesis.

Authors:  J Russo; L K Tay; I H Russo
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

5.  Urinary aetiocholanolone in patients with early breast cancer from South East Scotland and South Wales.

Authors:  W R Miller; T Hamilton; H R Champion; I W Wallace; A P Forrest; R J Prescott; E H Cameron; K Griffiths
Journal:  Br J Cancer       Date:  1975-11       Impact factor: 7.640

Review 6.  Molecular and cellular basis of the mammary gland susceptibility to carcinogenesis.

Authors:  J Russo; L K Tay; D R Ciocca; I H Russo
Journal:  Environ Health Perspect       Date:  1983-03       Impact factor: 9.031
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.